Breaking News
0
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. More details
Close

Relief Therapeutics Holding SA (RLFTF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.34 0.00    0.18%
05/03 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  CH0100191136 
  • Volume: 7,338,646
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 0.32 - 0.34
Relief Therapeutics 0.34 0.00 0.18%
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.33
Day's Range0.32 - 0.34
RevenueN/A
Open0.34
52 wk Range0.01 - 0.95
EPSN/A
Volume7,338,646
Market Cap1.05B
Dividend (Yield)N/A (N/A)
Average Volume (3m)11,827,788
P/E RatioN/A
BetaN/A
1-Year ChangeN/A
Shares OutstandingN/A
Next Earnings DateN/A
What is your sentiment on Relief Therapeutics Holding SA?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Buy Buy Neutral Strong Sell Buy
Technical Indicators Neutral Strong Buy BUY Strong Sell BUY
Summary Neutral Strong Buy Neutral Strong Sell Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Dragonfly Doji 1D Current
Harami Cross 1D Current
Completed Patterns
Stick Sandwich 5H 1 Mar 05, 2021 12:00
Homing Pigeon 5H 4 Mar 04, 2021 11:00
Doji Star Bearish 30 5 Mar 05, 2021 19:00

Relief Therapeutics Holding SA Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  Switzerland 0.3020 0.0000 0.0000 10,580,049 -4.73% CHF 05/03  
  OTC Markets 0.34 0.00 0.00 7,338,646 0.18% USD 05/03  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  FBN Holdings 7.10 7.10 6.85 +0.05 +0.71% 26.50M 05/03  
  MTN Nigeria 160.20 160.20 160.20 -9.80 -5.76% 643.20K 05/03  
  Guaranty Trust Bank 31.20 31.05 30.90 -0.50 -1.59% 20.83M 05/03  
  Zenith Bank 25.30 25.40 24.95 0.00 0.00% 46.85M 05/03  
  UBA 7.95 7.95 7.85 0.00 0.00% 23.30M 05/03  
  Access Bank 7.90 7.85 7.70 +0.10 +1.28% 10.47M 05/03  
  Dangote Sugar 16.90 16.90 16.40 +0.40 +2.42% 1.98M 05/03  
  Lafarge Africa 22.20 22.20 21.80 +2.00 +9.90% 1.65M 05/03  
  STANBIC IBTC Bank 44.00 44.00 44.00 +4.00 +10.00% 82.37K 05/03  
  Oando Plc 2.65 3.00 2.65 -0.25 -8.62% 4.05M 05/03  

Relief Therapeutics Holding SA Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

24

Equity Type

ORD

RELIEF THERAPEUTICS Holding SA is a Switzerland-based biopharmaceutical company. The Company’s objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need, as well as to focus on developing treatments for respiratory diseases. It specializes in clinical-stage projects based on molecules of natural origin (peptides and proteins with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications. RLF-100 is being investigated in two placebo-controlled U.S. phase 2b/3 clinical trials in respiratory deficiency due to COVID-19. Its RLF-100 is also used for pulmonary sarcoidosis. The company is also involved in the clinical development of RLF-100 that is in planning stage for other indications in acute and chronic lung diseases.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RLFB Comments

Write your thoughts about RELIEF THERAPEUTICS Holding SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email